9 Helicobacter pylori as a risk factor for cancer

https://doi.org/10.1016/0950-3528(95)90049-7Get rights and content

Abstract

In 1985, gastric cancer was the second most common cause of cancer death in the world. The rapid decline in gastric cancer rates over the last few decades has been attributed to a decline in the prevalence of environmental risk factors for gastric cancer and/or an increase in the prevalence of protective factors. One such risk factor could be the bacterium Helicobacter pylori. Epidemiological studies have shown that areas with high gastric cancer rates often have a correspondingly high prevalence of H. pylori and prospective studies have shown that subjects with serological evidence of H. pylori infection were significantly more likely to go on to develop gastric cancer than those who did not.

Helicobacter pylori itself does not appear to be either genotoxic or mutagenic. Infection is, however, associated with increased cell turnover, a chronic immune response accompanied by increased levels of reactive oxygen metabolites and a reduction in gastric levels of ascorbic acid, all conditions that could favour the development of cancer. Nonetheless, the majority of those who are infected with H. pylori do not go on to develop gastric cancer and other factors, such as the strain of the infecting organism or consumption of dietary antioxidants including vitamin C, could also affect the risk of cancer.

Finally, it has been estimated that more than one third, and possibly as many as 90% of gastric cancers might be attributable to infection with H. pylori. Prevention and treatment of infection are, therefore, possible approaches to reducing gastric cancer rates. It is, however, unclear what, if any, effect eradication of the infection would have on an individual's risk of gastric cancer and, to date, anti-Helicobacter therapy has only been shown to be of potential benefit in the treatment of low grade gastric MALT lymphomas.

References (109)

  • BN Ames et al.

    Too many rodent carcinogens: mitogenesis increases mutagenesis

    Science

    (1990)
  • A Archimandritis et al.

    Non-cardia gastric adenocarcinoma and Helicobacter pylori infection

    Italian Journal of Gastroenterology

    (1993)
  • M Asaka et al.

    Possible role of Helicobacter pylori infection in early gastric cancer development

    Cancer

    (1994)
  • N Banatvala et al.

    The cohort effect and Helicobacter pylori

    Journal of Infectious Diseases

    (1993)
  • S Banerjee et al.

    Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid

    Gut

    (1994)
  • DJP Barker et al.

    Poor housing in childhood and high rates of stomach cancer in England and Wales

    British Journal of Cancer

    (1990)
  • MJ Blaser

    Malaria and the natural history of Helicobacter pylori infection

    Lancet

    (1993)
  • MJ Blaser et al.

    Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach

    International Journal of Cancer

    (1993)
  • MJ Blaser et al.

    Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk

    Cancer Research

    (1995)
  • MJ Blaser et al.

    Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach

    Cancer Research

    (1995)
  • G Block et al.

    Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence

    Nutrition and Cancer

    (1992)
  • TJ Borody et al.

    Apparent reversal of early gastric-mucosal atrophy after triple therapy for Helicobacter pylori

    American Journal of Gastroenterology

    (1993)
  • F Brenes et al.

    Helicobacter pylori causes hyperproliferation of the gastric epithelium; pre- and post-eradication indices of proliferating cell nuclear antigen

    American Journal of Gastroenterology

    (1993)
  • E Buiatti et al.

    Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela

    Cancer Causes and Control

    (1994)
  • RJ Cahill et al.

    Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation

    Digestive Diseases and Science

    (1995)
  • J Chen et al.

    Diet, Life-style and Mortality in China

  • MP Coleman et al.

    Trends in Cancer Incidence and Mortality

    (1993)
  • P Correa

    A human model of gastric carcinogenesis

    Cancer Research

    (1988)
  • P Correa

    Human gastric carcinogenesis: a multistep and multifactorial process—first American cancer society award lecture on cancer epidemiology and prevention

    Cancer Research

    (1992)
  • P Correa et al.

    A model for gastric cancer epidemiology

    Lancet

    (1975)
  • P Correa et al.

    Gastric precancerous process in a high risk population: cross-sectional studies

    Cancer Research

    (1990)
  • P Correa et al.

    Gastric precancerous process in a high risk population: cohort follow-up

    Cancer Research

    (1990)
  • P Correa et al.

    Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks

    Cancer

    (1990)
  • JE Crabtree et al.

    Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology

    Lancet

    (1991)
  • JE Crabtree et al.

    Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer

    Gut

    (1993)
  • GR Davies et al.

    Helicobacter pylori, free radicals and gastroduodenal disease

    European Journal of Gastroenterology and Hepatology

    (1994)
  • GR Davies et al.

    Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo

    Gut

    (1994)
  • MF Dixon

    Helicobacter pylori and chronic gastritis

  • MF Dixon

    Acid, ulcers and H. pylori

    Lancet

    (1993)
  • C Doglioni et al.

    High incidence of primary gastric lymphoma in northeastern Italy

    Lancet

    (1992)
  • IM Drake et al.

    Reactive oxygen species in H. pylori infection

  • IM Drake et al.

    Reactive oxygen species (ROS) activity and damage in Helicobacter pylori associated gastritis effect of eradication therapy

    Gut

    (1995)
  • E El-Omar et al.

    Eradicating Helicobacter pylori infection lowers gastric mediated acid secretion by two-thirds in duodenal ulcer patients

    Gut

    (1993)
  • J Estevens et al.

    Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study

    European Journal of Cancer Prevention

    (1993)
  • N Figura et al.

    Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only

    Journal of Clinical Microbiology

    (1989)
  • D Forman et al.

    Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China

    International Journal of Cancer

    (1990)
  • D Forman et al.

    Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

    British Medical Journal

    (1991)
  • D Forman et al.

    H. pylori and gastric cancer

    Lancet

    (1994)
  • JG Fox et al.

    High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis

    American Journal of Gastroenterology

    (1992)
  • B Frei et al.

    Ascorbate is an outstanding antioxidant in human blood plasma

  • A Fukao et al.

    Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study

    Cancer Causes and Control

    (1993)
  • H Fukuda et al.

    Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan

    Japanese Journal of Cancer Research

    (1995)
  • PM Goggin et al.

    Factors affecting gastric mucosal hydrophobicity in man

    Scandinavian Journal of Gastroenterology

    (1991)
  • MB Grisham et al.

    Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats

    Gastroenterology

    (1992)
  • HM Hack et al.

    Reversal of intestinal metaplasia after treatment of H. pylori infection

    Gastroenterology

    (1994)
  • S Hansen et al.

    Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma

    American Journal of Gastroenterology

    (1994)
  • LE Hansson et al.

    Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma

    Gastroenterology

    (1993)
  • C Holcombe

    Helicobacter pylori: the African enigma

    Gut

    (1992)
  • CP Howson et al.

    The decline in gastric cancer: epidemiology of an unplanned triumph

    Epidemiologic Reviews

    (1986)
  • T Hussell et al.

    The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori

    Lancet

    (1993)

    • Cited by (60)

    • Anti-ulcer activity of Cyrtocarpa procera analogous to that of Amphipterygium adstringens, both assayed on the experimental gastric injury in rats

      2011, Journal of Ethnopharmacology
      Citation Excerpt :

      It has also been described that Amphipterygium adstringens possesses anti-Helicobacter pylori (H. pylori) activity (Castillo-Juárez et al., 2007), an etiologic agent that plays an important role in the pathogenesis of peptic ulcer disease. Epidemiological studies have shown that areas with high gastric cancer rates often have a correspondingly high prevalence of Helicobacter pylori and prospective studies have shown that subjects with serological evidence of Helicobacter pylori infection are significantly more likely to develop gastric alterations than those without this serologic memory (Webb and Forman, 1995). Anti-Helicobacter pylori activity for Cyrtocarpa procera was also previously suggested by Castillo-Juárez et al. (2007).

    • Endoscopic Therapy for Gastric Neoplasms

      2011, Clinical Gastrointestinal Endoscopy, Second Edition

    • Interleukin-6 Polymorphisms, Helicobacter pylori Infection in Adult Brazilian Patients with Chronic Gastritis and Gastric Adenocarcinoma

      2007, Archives of Medical Research
      Citation Excerpt :

      For example, noncardia gastric adenocarcinoma occurs excessively in patients with gastric atrophy and hypochlorhydria (20). The decline in incidence of noncardia gastric adenocarcinoma has paralleled the decreasing prevalence of infection with Helicobacter pylori, which plays an essential role in initiating this cancer (21). Host genetic factors are emerging as key determinants of disease risk for many cancers (22,23).

    • Gastric adenocarcinoma: Approach to a complex biological reality

      2007, Medicina Clinica

    • Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides

      2006, European Journal of Medicinal Chemistry
      Citation Excerpt :

      It is now recognized that Helicobacter pylori, an S-shaped spiral microaerophilic Gram-negative bacterium first isolated in human gastric mucosa in 1982 [1–3], is a pathogenic factor of chronic active gastritis, peptic ulcer disease, and gastric cancer [4–6] and its eradication can significantly reduce the risk of ulcer relapse and may help prevent mucosa-associated lymphoid tissue (MALT)-type gastric carcinoma and other gastric cancers [7–9].

    • Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives

      2005, Bioorganic and Medicinal Chemistry Letters
    View all citing articles on Scopus
    View full text
    Copyright © 1995 Published by Elsevier Ltd.